Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis

Fig. 2

Expression levels of the two most significantly different serum miRNAs. The absolute expression levels of the two most significantly deregulated serum miRNAs, hsa-miR-410-3p and hsa-miR-16-2-3p, in the three-group comparison of patients with NMOSD, CIS/RRMS, and healthy controls by ANOVA are shown as boxplots. CIS clinically isolated syndrome, RRMS relapsing-remitting multiple sclerosis, NMOSD neuromyelitis optica spectrum disorder

Back to article page